GlassScriptPhysician profile
James G Cunnar
NPI 1164538617
$5,219.47
in general payments reported to CMS, 2019-2025
53 companies · $979 in 2025
The $979 reported for 2025 was more than what 86% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $589 · 2021: $595 · 2022: $407 · 2023: $718 · 2024: $1,117 · 2025: $979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,813.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $675.90 | 2019-2025 | Vraylar, Ubrelvy, Qulipta |
| Novo Nordisk INC | $621.88 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $472.16 | 2019-2025 | Mounjaro, Emgality, Jardiance |
| Astrazeneca Pharmaceuticals LP | $346.47 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Amgen INC. | $248.02 | 2019-2025 | Repatha, Otezla, Krystexxa |
| Pfizer INC. | $228.80 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $187.40 | 2019-2024 | |
| Exact Sciences Corporation | $147.20 | 2023-2025 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $144.86 | 2019-2022 | |
| Antares Pharma, INC. | $136.73 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Sanofi Pasteur INC. | $127.85 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $112.66 | 2019-2021 | |
| Abbott Laboratories | $107.97 | 2019-2025 | Freestyle Libre 3 |
| Dexcom, INC. | $99.80 | 2024-2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $98.86 | 2019-2021 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cunnar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.